Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: Teva Pharmaceutical Industries Ltd’s rival migraine headache preventer is excluded on one list and patients can pay more for it in some cases on a second list, the note said. As with rival PBMs Express Scripts and CVS Health Corp, OptumRx’s lists of covered drugs, or formularies, cover tens of millions of consumers who receive their healthcare from employers and health insurers. About 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation, and global migraine drug sales could reach $8.7 billion by 2026, according to analytics firm GlobalData. OptumRx’s decision secures easier access to customers for Lilly’s Emgality at all three of the biggest PBMs - including CVS and Express Scripts - and gives Amgen’s Aimovig a leg up after CVS decided not to include it on its preferred drug list. Teva’s Ajovy only has preferred status at CVS, while Amgen also has it at Express Scripts, part of Cigna Corp.  “We are pleased that all three companies have chosen Emgality to be one of the preferred medications, making it accessible to even more patients suffering from migraine,” Lilly said in an emailed statement. Inclusion on a preferred drugs list by the largest PBMs and health insurers is critically important for sales of new medicines. Increasingly, PBMs are choosing a subset of treatments for their coverage list when there are multiple treatments that are considered equivalent. The three treatments, approved by the U.S. Food and Drug Administration last year, belong to a class of drugs called CGRP inhibitors that have proven effective in helping to prevent migraines. A Teva spokeswoman said the company is committed to increasing access to Ajovy regardless of formulary decisions and is still offering discounts that allow patients to pay nothing in some cases, regardless of insurance. “Since Ajovy injection launched in September, we have experienced strong demand and steady growth, and we continue discussions with payers,” the spokeswoman said. An Amgen spokeswoman said that the company was pleased with the decision and is committed to ensuring affordable access to its drug. Amgen, which shares Aimovig U.S. revenue with Novartis AG, earlier this week reported fourth-quarter sales of $95 million, nearly doubling Wall Street estimates. The OptumRx decision becomes effective Feb. 1. The OptumRx select formulary relegates Teva’s drug to a lower access level that would typically require a higher out-of-pocket cost, it said. PBMs typically extract discounts from drugmakers in return for favorable placement on their preferred list of covered drugs, such as through a low co-payment, or coinsurance payment, for their members. All three migraine drugs have a list price of $575 a month, or $6,900 a year. Those prices do not reflect the rebates and discounts to PBMs, who design and negotiate benefits for employers and insurers. All three drugmakers are providing a limited duration supply of the new drugs at no cost directly to patients in addition to other assistance programs. Amgen’s Aimovig was first-to-market from the new class. But the rivals from Teva and Lilly followed soon after. The three large PBMs together cover the majority of the more than 150 million Americans who receive benefits through their employers. Their clients, including insurers and corporations, may choose not to follow a PBM’s recommendations on coverage, but that typically would cost more. Amgen shares were off 28 cents at $186.63, Lilly was up nearly 1 percent at $120.90 and Teva shares traded in New York  were down nearly 1 percent at $19.69.

Output: Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva.


Input: Consider Input: "Bounciest Democrat on November's statewide ballot? It might be Hank Gilbert, making his second hard charge for state agriculture commissioner versus Todd Staples, the Republican who topped him four years ago. Gilbert, ever prowling for issues, recently trumpeted that the Texas Department of Agriculture is looking at buying thousands of stress balls -- squeezable toys. He said in a Sept. 24 press release: ""Make no mistake, Texans love their balls: footballs, baseballs, basketballs, and soccer balls. But 300,000 stress balls? It seems a little extreme, but that's the quantity of grape, barbell, and book-shaped polyurethane stress balls the Texas Department of Agriculture could be spending taxpayer dollars on...""  Really? To our inquiry, Gilbert's campaign provided Web links to the agriculture agency's June request for bids as well as a September post on a state website indicating that a $99,000 contract to provide promotional materials was awarded to a Massachusetts company, Oceans Promotions. We downloaded the June 29 bid-request package from a site for state requisitions overseen by the state comptroller's office. The package shows the department was seeking bids to provide up to 300,000 stress ""relievers,"" which we're guessing are not balls because they're not round. Precisely, the package says, the agency sought bids to make ""promotional items with logo imprints to follow through on (the) TDA Food and Nutrition Texans Bring It Campaign,"" with the items to include grape-shaped stress relievers with ""Texans Bring It"" written on them or ""Eating Right,"" which would be made of polyurethane and be two inches high by three inches wide. The package says a second set of stress relievers, each one called ""Dumbbell,"" would be imprinted ""Texans Bring It"" and ""Exercise"" and be five inches high by 1.8 inches in diameter. A third stress reliever would be imprinted ""Book"" and ""Texans Bring It,"" according to the bid package, while other promotional items would include pencils, buttons and bumperstickers. The package says the bids were sought for various quantities, starting from 2,500 and topping out at 100,000 each. It electronically links to a Branders.com site showing what the agency wanted the stress relievers to look like (our interpretation: bunches of purple grapes). Is all this a real deal? To our inquiry, Bryan Black, Staples' spokesman, replied via e-mail: ""An invitation for bid was issued for these federally funded educational items to reduce the $5.8 billion avoidable health care expenditures, paid by taxpayers, associated with overweight and obesity health problems."" We followed up with Black, asking if it's accurate to conclude that up to 300,000 of the stress relievers are being purchased. We also wondered why the purchase was being made. Black said he'd limit his comment to his e-mailed statement. Surely the agency would pipe up if Gilbert got its purchase plans wrong."

Output: Hank Gilbert Says the Texas Department of Agriculture seeks to purchase up to 300,000 promotional stress balls.


Input: Consider Input: Australia has avoided the high numbers of coronavirus casualties reported in other countries around the world after closing its borders and imposing strict “social distancing” measures for the past month. Restaurants, bars and other “non-essential” businesses have closed and public gatherings of more than two people have been banned under the threat of fines and even prison - measures that are expected to double the unemployment rate by mid-year. In response, the daily growth rate of reported new infections has steadied in the low percentage single digits, from about 25% several weeks ago, for a total of about 6,500 infections, including 63 deaths. Still, Morrison said the rules would not be relaxed until national testing capacity has been increased, contact tracing of known COVID-19 cases expanded and a response to any future outbreak fully prepared. “We want to be very clear with Australians, baseline restrictions we have in place at the moment, there are no plans to change those for the next four weeks,” Morrison told reporters. Morrison later told the Australian Broadcasting Corporation that coronavirus testing may be expanded to include random sampling. An eventual staggered relaxation on restrictions was likely, he said, with curbs on manufacturing and retail industries being  eased first. Morrison has in recent days pushed state and territory leaders to re-open schools. Morrison has cited medical advice that children carry a low risk of transmitting the virus as he advocated for the re-opening schools to help boost the economy, which is headed for its first recession in three decades.. However, some leaders of the eight states and territories - which administer schools - have departed from that policy and ordered schools to remain shut to all but the children of “essential” workers, including those in the health and grocery sectors. In Victoria, the second most populous state where officials have told parents to keep children at home if possible, just 3% of children attended school on Tuesday, the first day after the Easter break. Students in other states and territories remain on mid-term vacation. An agreement on the issue was not reached at a meeting on Thursday of the national cabinet, made up of state and federal leaders, formed to tackle the crisis. Chief Medical Officer Brendan Murphy said Australia’s choice of a “suppression” strategy, as opposed to a full shutdown of public life as adopted by neighbour New Zealand, could free the country of the virus without hefty economic penalties. “We don’t feel the need to hold the country very seriously in lockdown until we have no cases,” Murphy said. “If that happens with the measures we are doing now, that would be fantastic.”  In Sydney, police entered the Villawood immigration detention centre to end rooftop and hunger strike protests begun by some refugee inmates on Saturday. Three detainees who refused to come down from the roof were arrested and taken into custody. Detainees were angry the government has refused pleas to release them from the centre amid the health crisis and denied them testing. While some countries have released some non-violent detainees from prisons and detention centres, Australia has so far refused to do so. (This story was refiled to fix “contract” to “contact” in paragraph 5)


Output: Australia to retain coronavirus curbs for at least another four weeks.